ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS..SM..................JBDM Ver 0.1.67 (18 Oct 2017) - 2999001/03184546CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120191030W173deBibliographieenBibliographyfrBibliographieEP16199717.6200912182016112120180130enenen203569 P20081223US264622 P20091125US2019103020194420170628201726201907172019292019013020191030201944C07K 16/28 20060101AFI20170302BHEP C07K 14/72 20060101ALI20170302BHEP deAN DEN HUMANEN CGRP-REZEPTOR BINDENDE ANTIKÖRPERenHUMAN CGRP RECEPTOR BINDING ANTIBODIESfrANTICORPS SE LIANT AU RÉCEPTEUR CGRP HUMAINMCLATCHIE L M ET AL: "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.", NATURE 28 MAY 1998, vol. 393, no. 6683, 28 May 1998 (1998-05-28), pages 333-339, XP002767658, ISSN: 0028-0836Committee on Methods of Producing MonoclonalAntibodies, Institute for Laboratory Animal Research,National Research Council: "Monoclonal Antibody Production", 1999, National Academy Press, Washington, DC, XP002767659, ISBN: 0-309-51904-7 * page 10 *TAYLOR CHRISTOPHER K ET AL: "PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ALPHA-CALCITONIN GENE-RELATED PEPTIDE (CGRP) RECEPTOR PEPTIDE ANTAGONISTS THAT ARE SELECTIVE FOR HUMAN CGRP RECEPTORS", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 319, no. 2, 1 November 2006 (2006-11-01), pages 749-757, XP009084228, ISSN: 0022-3565DAVIS CARL D ET AL: "The Tortuous Road to an Ideal CGRP Function Blocker for the Treatment of Migraine", CURRENT TOPICS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 8, no. 16, 1 November 2008 (2008-11-01), pages 1468-1479, XP008119816, ISSN: 1568-0266CHAUHAN M ET AL: "Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery.", June 2004 (2004-06), BIOLOGY OF REPRODUCTION JUN 2004, VOL. 70, NR. 6, PAGE(S) 1658 - 1663, XP002571487, ISSN: 0006-3363 * the whole document *DURHAM PAUL L: "CGRP-RECEPTOR ANTAGONISTS--A FRESH APPROACH TO MIGRAINE THERAPY?", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 350, no. 11, 11 March 2004 (2004-03-11), pages 1073-1075, XP009082423, ISSN: 1533-4406TEPPER STEWART ET AL: "Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 16, no. 6, 28 April 2017 (2017-04-28) , pages 425-434, XP085003376, ISSN: 1474-4422, DOI: 10.1016/S1474-4422(17)30083-209775072.323795942009121819181187.620190619BOONE, Thomas Charles2715 Kelly Knoll LaneNewbury Park CA 91320USBRANKOW, David W.18800 Tribune StreetNorthridge CA 91326USGEGG, Colin V., Jr.31121 Village 31,Camarillo, CA 93012USHU, Shaw-Fen Sylvia986 Lynnmere DriveThousand Oaks, CA 91360USKing, Chadwick T.1325 Moody AvenueNoreth Vancouver, BC V7L 3T5CALU, Hsieng Sen2758 Rainfield AvenueThousand Oaks, CA 91362USSHI, Licheng5243 Via CapoteNewbury Park, CA 91320USXU, Cen5221 Via JacintoNewbury Park, CA 91320USAmgen Inc.101250726EP76466IHVGSsroOne Amgen Center DriveThousand Oaks, California 91320-1799USGrünecker Patent- und Rechtsanwälte PartG mbB100060488Leopoldstraße 480802 MünchenDEATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKSMTRAL20171218BA20171218RS20171218